S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
NASDAQ:TMDI

Titan Medical - TMDI Stock Forecast, Price & News

$0.52
-0.01 (-1.89%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.51
$0.53
50-Day Range
$0.47
$0.64
52-Week Range
$0.38
$1.78
Volume
75,071 shs
Average Volume
240,308 shs
Market Capitalization
$57.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Titan Medical MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.28% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.46mentions of Titan Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.35) to ($0.26) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.12 out of 5 stars

Medical Sector

1104th out of 1,122 stocks

Surgical & Medical Instruments Industry

111th out of 112 stocks

TMDI stock logo

About Titan Medical (NASDAQ:TMDI) Stock

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

Titan Medical Stock Performance

Titan Medical stock opened at $0.53 on Wednesday. Titan Medical has a 12 month low of $0.38 and a 12 month high of $1.78. The company's fifty day simple moving average is $0.54 and its 200-day simple moving average is $0.53.

Receive TMDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter.

TMDI Stock News Headlines

Titan Medical (TMDI) to Release Quarterly Earnings on Thursday
Titan Medical Announces Executive Departure
Titan Medical reports Q1 results
Titan Medical Q1 2022 Earnings Preview
Titan Medical's Earnings Outlook
Titan Medical stock falls 6% amid FY21 results
Titan Medical reports FY results
Titan Medical FY Earnings Preview
See More Headlines
Receive TMDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter.

TMDI Company Calendar

Last Earnings
11/11/2021
Today
8/17/2022
Next Earnings (Estimated)
11/10/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TMDI
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Net Income
$-14,860,000.00
Pretax Margin
-191.72%

Debt

Sales & Book Value

Annual Sales
$20.09 million
Book Value
$0.14 per share

Miscellaneous

Free Float
N/A
Market Cap
$57.93 million
Optionable
Not Optionable
Beta
2.52

Key Executives

  • Mr. Cary G. Vance (Age 56)
    CEO, Pres & Director
    Comp: $56.18k
  • Mr. Stephen L. Lemieux BA
    CA, CPA, MMPA, Chief Financial Officer
  • Mr. Jasminder Brar
    VP of Legal, IP & Strategic Initiatives, Corp. Sec. and Gen. Counsel
  • Ms. Kristen P. Galfetti
    VP of Investor Relations & Corp. Communications
  • Ms. Tammy Barnes Carrea
    VP of Quality and Regulatory Affairs













TMDI Stock - Frequently Asked Questions

Should I buy or sell Titan Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TMDI shares.
View TMDI analyst ratings
or view top-rated stocks.

How have TMDI shares performed in 2022?

Titan Medical's stock was trading at $0.6251 at the start of the year. Since then, TMDI stock has decreased by 16.0% and is now trading at $0.5250.
View the best growth stocks for 2022 here
.

When is Titan Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 10th 2022.
View our TMDI earnings forecast
.

How were Titan Medical's earnings last quarter?

Titan Medical Inc. (NASDAQ:TMDI) posted its earnings results on Thursday, November, 11th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.02. During the same quarter in the prior year, the company earned ($0.02) earnings per share.

What other stocks do shareholders of Titan Medical own?
What is Titan Medical's stock symbol?

Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."

Who are Titan Medical's major shareholders?

Titan Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Essex LLC (1.80%).

How do I buy shares of Titan Medical?

Shares of TMDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Titan Medical's stock price today?

One share of TMDI stock can currently be purchased for approximately $0.53.

How much money does Titan Medical make?

Titan Medical (NASDAQ:TMDI) has a market capitalization of $58.49 million and generates $20.09 million in revenue each year. The company earns $-14,860,000.00 in net income (profit) each year or ($0.18) on an earnings per share basis.

How can I contact Titan Medical?

Titan Medical's mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The official website for the company is www.titanmedicalinc.com. The company can be reached via phone at (416) 548-7522.

This page (NASDAQ:TMDI) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.